Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction

• Conditions: Acute Myocardial Infarction; Percutaneous Coronary Intervention; Coronary Artery Disease

• Registration Number: NCT02641184
• Lead Sponsor: Zhejiang Provincial People's Hospital

Brief Summary

The aim of this study is to investigate the potential novel risk factors for acute myocardial infarction. Predictors of poor outcomes will be also evaluated.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-12
• Study First Submitted: 2015-12-14
• Study First Submitted QC: 2015-12-28
• Study First Posted: 2015-12-29
• Status Verified: 2016-02
• Last Update Submitted: 2016-02-13
• Last Update Posted: 2016-02-17
• Primary Completion: 2017-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 3000

Inclusion Criteria

• Less than 12 hours after the onset of myocardial infarction symptoms
• Myocardial necrosis, as evidenced by increased Creatine Kinase Isoenzyme (CK-MB) or troponin levels

Exclusion Criteria

• Age under 18 years-old

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Major adverse cardiovascular events (MACE)	maximum 5 years	Composite of angina pectoris, reinfarction, unplanned rehospitalization, stent thrombosis, incidence of cardiac death in the duration of follow-up

Secondary Outcome Measures

Name	Time	Method
New-onset diabetes	the duration of follow-up, maximum 5 years	New-onset diabetes are defined as newly-diagnosed type 2 diabetes mellitus
Length of hospital stay	in the phase of hospital stay, maximum 30 days	The length of in-hospital stay is counted as a secondary outcome

Trial Locations

Locations (1)

Zhejiang provincial people's hospital; 🇨🇳 Hangzhou, Zhejiang, China